US2006115533A1PendingUtilityA1

Pharmaceutical compositions

58
Assignee: GUITARD PATRICEPriority: Jul 14, 1995Filed: Oct 21, 2005Published: Jun 1, 2006
Est. expiryJul 14, 2015(expired)· nominal 20-yr term from priority
Inventors:Patrice GuitardBarbara HaeberlinRainer LinkFriedrich Richter
A61P 39/02A61P 5/14A61P 37/00A61P 7/00A61P 37/06A61P 37/02A61P 3/10A61P 3/00A61P 27/02A61P 31/10A61P 35/00A61P 31/00A61P 29/00A61P 31/04A61P 21/00A61P 17/08A61P 21/04A61K 31/436A61P 17/10A61K 9/146A61P 17/06A61K 31/445A61P 17/02A61P 19/02A61K 9/145A61P 17/14A61K 31/4745A61P 11/00A61P 1/00A61P 17/00A61K 9/14A61K 47/50
58
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A pharmaceutical composition in the form of a solid dispersion comprising a macrolide, e.g. a rapamycin or an ascomycin, and a carrier medium.

Claims

exact text as granted — not AI-modified
1 - 10 . (canceled)  
   
   
       11 . A method of forming a pharmaceutical composition comprising 33-epi-chloro-33-desoxy-ascomycin and a carrier medium wherein the method comprises: 
 (a) suspending the 33-epi-chloro-33-desoxy-ascomycin in a solvent to form a suspension,    (b) combining one or more carrier components with the solvent, and    (c) spray drying the suspension to form the pharmaceutical composition.

Join the waitlist — get patent alerts

Track US2006115533A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.